Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TCA-101 by TCR Cure Biopharma Technology for Endometrial Cancer: Likelihood of Approval
TCA-101 is under clinical development by TCR Cure Biopharma Technology and currently in Phase II for Endometrial Cancer. According to...
Data Insights
TCA-101 by TCR Cure Biopharma Technology for Solid Tumor: Likelihood of Approval
TCA-101 is under clinical development by TCR Cure Biopharma Technology and currently in Phase II for Solid Tumor. According to...